Skip to main content

Month: April 2026

MainStreet Bancshares, Inc. Announces First Quarter 2026 Results

Net Interest Margin Expands on Disciplined Funding Strategy FAIRFAX, Va., April 20, 2026 (GLOBE NEWSWIRE) — MainStreet Bancshares, Inc. (Nasdaq: MNSB & MNSBP), the financial holding company for MainStreet Bank, reported a net income of $4.1 million for the quarter-ended March 31, 2026, resulting in earnings per common share of $0.48. The net interest margin expanded 9 basis points during the quarter to 3.47%, resulting from consistent loan pricing and lower funding costs. During the quarter the Company executed a buyback of 273,448 shares, and the book value per common share ended the quarter at $25.63.  The Company and Bank remain strongly capitalized. “Our team’s disciplined execution continues to drive value for our shareholders.  With robust liquidity and a growing book value, we leveraged our share buyback program to take...

Continue reading

Nanox Announces Fourth Quarter of 2025 Financial Results and Provides Business Updates

Advanced commercialization in the US, signing multiple new customer and distribution agreements for Nanox.ARC and accelerated activities around Nanox.AI Management to host conference call and webcast Monday, April 20, 2026 at 8:30 AM ET Appointed new CFO effective August 1, 2026 PETAH TIKVA, Israel, April 20, 2026 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the fourth quarter ended December 31, 2025, and provided a business update. Recent Highlights:Generated $3.7 million in revenue in the fourth quarter of 2025, compared to $3.0 million in the fourth quarter of 2024. Completed the acquisition of 100% of the stock of Vaso Healthcare IT Corp. (now Nanox Health IT Inc., “Nanox Health IT”), a provider of healthcare information...

Continue reading

Nayax at the NAMA Show 2026: Turning Payment Complexity into a Competitive Edge

HERZLIYA, Israel, April 20, 2026 (GLOBE NEWSWIRE) — Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement, payments, and loyalty platform designed to help merchants scale their business, today announced its participation as both exhibitor and sponsor at the NAMA Show 2026 – the industry’s largest annual conference for vending and convenience service professionals – taking place April 22-24, 2026 in Los Angeles, CA. The NAMA Show is the premier gathering for unattended retail operators across North America. This year Nayax will be at Booth #1929 with a clear message: complexity in unattended retail can be turned into a strength with the right partner. Nayax delivers an integrated, end-to-end platform designed around how operators run their business. That means the freedom to deploy the right solution...

Continue reading

Turbo Energy and Hithium Partner to Integrate AI-Driven Energy Optimization Software Into Battery Storage Systems Across Europe and Latin America

Partnership enables the integration of Turbo Energy’s AI-driven software into battery storage systems, supporting expansion of its high-margin international C&I pipelineHithium battery storage system powered by Turbo Energy’s AI-driven optimization platformHithium battery storage system powered by Turbo Energy’s AI-driven optimization platformHithium battery storage system powered by Turbo Energy’s AI-driven optimization platform VALENCIA, Spain, April 20, 2026 (GLOBE NEWSWIRE) — Turbo Energy, S.A. (Nasdaq: TURB) (“Turbo Energy” or the “Company”), a global integrator of AI-driven solar energy storage solutions and intelligent energy management systems, today announced strategic partnership with Hithium, a tier 1 global battery storage provider, to integrate its AI-driven optimization platform into Hithium’s battery...

Continue reading

PharmAla Biotech Positioned to Supply U.S. Expanded Access Pathway for MDMA Established by Presidential Executive Order

Company Advances Next-generation Patented MDMA Toward Patient Dosing in 2026 TORONTO, April 20, 2026 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF) (“PharmAla” or the “Company”), a global leader in the research, development and manufacturing of MDMA and next-generation MDXX class molecules, today responded to the Executive Order signed on April 18, 2026 by the President of the United States, which directs the U.S. Food and Drug Administration (“FDA”) and the U.S. Drug Enforcement Administration (“DEA”) to establish a pathway for eligible patients to access investigational psychedelic drugs, and directs the FDA Commissioner to issue National Priority Vouchers to appropriate psychedelic drugs that have received Breakthrough Therapy designation. Positioned...

Continue reading

Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions

NEW YORK and TORONTO, April 20, 2026 (GLOBE NEWSWIRE) — Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP), a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today welcomed the White House Executive Order aimed at accelerating research, regulatory pathways, and patient access to psychedelic treatments. “The Executive Order reflects growing recognition of the urgent need for new treatment options in serious mental health conditions and the importance of advancing innovative therapies through rigorous, research-based development,” said Eric So, Interim Chief Executive Officer of Helus Pharma. “Policy momentum is meaningful, but the future of this field will ultimately be determined by the strength of the clinical evidence and the ability to deliver safe, reliable...

Continue reading

Nanox Signs Commercial Agreement with Howard Technology Solutions to Deploy 300 Nanox.ARC Systems Across U.S. Over Three Years

Howard’s nationwide reach across healthcare and public sector markets expands Nanox’s U.S. channel partner network to additional customer segments PETAH TIKVA, Israel, April 20, 2026 — Nano-X Imaging Ltd. (“Nanox”, or the “Company”, Nasdaq: NNOX), a leader in innovative medical imaging technology, today announced a strategic commercial agreement with Howard Technology Solutions, a leading U.S.-based technology solutions provider with deep expertise in healthcare and a broad national footprint. The agreement will support the commercial rollout of the Nanox.ARC, an FDA-cleared, multisource digital tomosynthesis system that makes 3D imaging possible in more clinical settings, at a lower cost and reduced radiation dose compared to traditional CT. Under the terms of the agreement, Howard Technology Solutions will market and deploy 300...

Continue reading

Foresight Enters Non-Binding Term Sheet for $17.5 Million Strategic Investment at Significant Premium to Current Market Price and Focus on Defense Collaboration

The strategic equity investment reflects a multiple of three times of Foresight’s current market value to reach a post investment valuation of approximately $35 million NESS ZIONA, Israel, April 20, 2026 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, today announced that it has entered into a non-binding term sheet with VisionWave Holdings, Inc. (Nasdaq: VWAV) (“VisionWave”), a defense and advanced sensing technology company. Pursuant to the term sheet, at closing, VisionWave will make a strategic equity investment of up to $17.5 million (but not less than $15.45 million) through the issuance of VisionWave common stock based on the five-day average closing price of VisionWave’s common stock prior to closing. In exchange, VisionWave...

Continue reading

YY Group Reports Unaudited Second Half and Full Year 2025 Earnings Results Highlighting Accelerating Revenue Growth, Expanding Margins and Positioning for Profitability in 2026

Full year revenue grew 39.3% year over year to US$57.2 million, with second half revenue of US$31.5 million Singapore, April 20, 2026 (GLOBE NEWSWIRE) — YY Group Reports Unaudited Second Half and Full Year 2025 Earnings Results Highlighting Accelerating Revenue Growth, Expanding Margins and Positioning for Profitability in 2026 Full year revenue grew 39.3% year over year to US$57.2 million, with second half revenue of US$31.5 million Full year gross profit increased 50.2% year over year to US$7.9 million, with gross profit margin expanding to 13.8% from 12.8% in 2024 Company expects to achieve non-IFRS net profitability in fiscal year 2026; formal profitability guidance to follow YY Group Holding Limited (NASDAQ: YYGH) (“YY Group” or the “Company”), a global leader in on-demand workforce solutions and integrated facilities management...

Continue reading

Swvl Announces FY 2025 Results; Revenue Up 41% to $24.2 million; Net Income $1.3 million; NDR of 128%; GCC Revenue Up 122%

Net income of $1.3M in FY 2025 versus net loss of $10.3M in FY 2024 Revenue grew by 41% to $24.2M; GCC revenue more than doubled (+122%) Operating loss narrowed by 94% to $0.5M from $8.5M, approaching operating profitability Recurring revenue increased to 84%; dollar-pegged revenue reached 33% of total revenue Net Dollar Retention reached 128% across all markets in USD and sales backlog of $38.2M Total equity returned to positive $2.9M DUBAI, United Arab Emirates, April 20, 2026 (GLOBE NEWSWIRE) — Swvl Holdings Corp (“Swvl” or the “Company”, and together with the Company’s subsidiaries, the “Group”) (NASDAQ: SWVL), a leading provider of technology-enabled mass mobility solutions for enterprises and governments, today announced its financial results for the fiscal year ended December 31, 2025 (“FY 2025”). Swvl delivered a financial...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.